Vanda Pharmaceuticals Inc.
DE ˙ DB ˙ US9216591084
5,26 € ↑0,09 (1,74%)
2026-06-05
DEL PRIS
SecurityDE:VM4 / Vanda Pharmaceuticals Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership450,981 shares
Latest Disclosed Value $ 3,116,278
Northern Trust Corp reports 5.10% increase in ownership of VM4 / Vanda Pharmaceuticals Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 450,981 shares of Vanda Pharmaceuticals Inc. (DE:VM4) valued at $2,593,141 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 429,113 shares of Vanda Pharmaceuticals Inc.. This represents a change in shares of 5.10% during the quarter. The current value of the position is $2,372,160 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F VANDA PHARMACEUTICALS COM 921659108 450,981 21,868 5.10 3,116 -17.65 0.0001
2026-02-17 2025-12-31 13F VANDA PHARMACEUTICALS COM 921659108 429,113 -25,459 -5.60 3,785 66.84 0.0005
2025-11-14 2025-09-30 13F VANDA PHARMACEUTICALS COM 921659108 454,572 -4,552 -0.99 2,268 4.66 0.0003
2025-08-13 2025-06-30 13F VANDA PHARMACEUTICALS COM 921659108 459,124 -30,250 -6.18 2,167 -3.52 0.0003
2025-05-13 2025-03-31 13F VANDA PHARMACEUTICALS COM 921659108 489,374 -18,068 -3.56 2,246 -7.57 0.0003
2025-02-14 2024-12-31 13F VANDA PHARMACEUTICALS COM 921659108 507,442 6,283 1.25 2,431 3.40 0.0003
2024-11-13 2024-09-30 13F VANDA PHARMACEUTICALS COM 921659108 501,159 14,248 2.93 2,350 -14.58 0.0004
2024-08-14 2024-06-30 13F VANDA PHARMACEUTICALS COM 921659108 486,911 -7,829 -1.58 2,751 35.32 0.0005
2024-05-14 2024-03-31 13F VANDA PHARMACEUTICALS COM 921659108 494,740 -13,845 -2.72 2,033 -5.27 0.0004
2024-02-13 2023-12-31 13F VANDA PHARMACEUTICALS COM 921659108 508,585 -52,752 -9.40 2,146 -11.47 0.0004
2023-11-13 2023-09-30 13F VANDA PHARMACEUTICALS COM 921659108 561,337 -34,163 -5.74 2,425 -38.23 0.0005
2023-08-11 2023-06-30 13F VANDA PHARMACEUTICALS COM 921659108 595,500 -783 -0.13 3,924 -3.06 0.0008
2023-05-15 2023-03-31 13F VANDA PHARMACEUTICALS COM 921659108 596,283 10,260 1.75 4,049 -6.51 0.0008
2023-02-13 2022-12-31 13F VANDA PHARMACEUTICALS COM 921659108 586,023 -8,567 -1.44 4,331 -26.30 0.0009
2022-11-14 2022-09-30 13F VANDA PHARMACEUTICALS COM 921659108 594,590 -2,551 -0.43 5,875 -9.74 0.0013
2022-08-12 2022-06-30 13F VANDA PHARMACEUTICALS COM 921659108 597,141 232 0.04 6,509 -3.58 0.0014
2022-05-13 2022-03-31 13F VANDA PHARMACEUTICALS COM 921659108 596,909 -195,342 -24.66 6,751 -45.69 0.0012
2022-02-08 2021-12-31 13F VANDA PHARMACEUTICALS COM 921659108 792,251 -7,221 -0.90 12,431 -9.28 0.0020
2021-11-15 2021-09-30 13F VANDA PHARMACEUTICALS COM 921659108 799,472 -20,681 -2.52 13,703 -22.33 0.0024
2021-08-13 2021-06-30 13F VANDA PHARMACEUTICALS COM 921659108 820,153 194,483 31.08 17,642 87.74 0.0031
2021-05-12 2021-03-31 13F VANDA PHARMACEUTICALS COM 921659108 625,670 -24,562 -3.78 9,397 9.98 0.0017
2021-02-11 2020-12-31 13F VANDA PHARMACEUTICALS COM 921659108 650,232 -33,695 -4.93 8,544 29.32 0.0017
2020-11-16 2020-09-30 13F VANDA PHARMACEUTICALS COM 921659108 683,927 -27,624 -3.88 6,607 -18.84 0.0014
2020-08-14 2020-06-30 13F VANDA PHARMACEUTICALS COM 921659108 711,551 -8,525 -1.18 8,141 9.13 0.0019
2020-05-14 2020-03-31 13F VANDA PHARMACEUTICALS COM 921659108 720,076 4,126 0.58 7,460 -36.51 0.0021
2020-02-14 2019-12-31 13F VANDA PHARMACEUTICALS COM 921659108 715,950 -16,983 -2.32 11,749 20.71 0.0026
2019-11-13 2019-09-30 13F VANDA PHARMACEUTICALS COM 921659108 732,933 26,267 3.72 9,733 -2.25 0.0023
2019-08-13 2019-06-30 13F VANDA PHARMACEUTICALS COM 921659108 706,666 6,938 0.99 9,957 -22.66 0.0024
2019-05-13 2019-03-31 13F VANDA PHARMACEUTICALS COM 921659108 699,728 4,290 0.62 12,875 -29.15 0.0032
2019-02-12 2018-12-31 13F VANDA PHARMACEUTICALS COM 921659108 695,438 -6,583 -0.94 18,173 12.80 0.0051
2018-11-14 2018-09-30 13F VANDA PHARMACEUTICALS COM 921659108 702,021 25,721 3.80 16,111 25.05 0.0039
2018-09-18 2018-06-30 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 676,300 91,539 15.65 12,884 30.76 0.0033
2018-08-14 2018-06-30 13F VANDA PHARMACEUTICALS COM 921659108 678,954 94,193 12,935
2018-05-09 2018-03-31 13F VANDA PHARMACEUTICALS COM 921659108 584,761 6,730 1.16 9,853 12.14 0.0026
2018-02-14 2017-12-31 13F VANDA PHARMACEUTICALS COM 921659108 578,031 -13,755 -2.32 8,786 -17.06 0.0022
2017-11-13 2017-09-30 13F VANDA PHARMACEUTICALS COM 921659108 591,786 -6,142 -1.03 10,593 8.68 0.0028
2017-08-11 2017-06-30 13F VANDA PHARMACEUTICALS COM 921659108 597,928 84,834 16.53 9,747 35.70 0.0027
2017-05-12 2017-03-31 13F VANDA PHARMACEUTICALS COM 921659108 513,094 28,542 5.89 7,183 -7.06 0.0021
2017-02-13 2016-12-31 13F VANDA PHARMACEUTICALS COM 921659108 484,552 2,533 0.53 7,729 -3.64 0.0024
2016-11-09 2016-09-30 13F VANDA PHARMACEUTICALS COM 921659108 482,019 -578 -0.12 8,021 48.51 0.0025
2016-08-12 2016-06-30 13F VANDA PHARMACEUTICALS COM 921659108 482,597 -46,656 -8.82 5,401 22.06 0.0018
2016-08-19 2016-03-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 529,253 23,202 4.58 4,425 -6.07 0.0015
2016-05-13 2016-03-31 13F VANDA PHARMACEUTICALS COM 921659108 529,253 4,425
2016-02-12 2015-12-31 13F VANDA PHARMACEUTICALS COM 921659108 506,051 28,620 5.99 4,711 -12.52 0.0016
2015-11-12 2015-09-30 13F VANDA PHARMACEUTICALS COM 921659108 477,431 477,431 0.00 5,385 0.0018
2015-08-13 2015-06-30 13F VANDA PHARMACEUTICALS COM 921659108 0 -462,602 -100.00 0 -100.00
2015-05-14 2015-03-31 13F VANDA PHARMACEUTICALS COM 921659108 462,602 14,804 3.31 4,303 -32.89 0.0013
2015-02-12 2014-12-31 13F VANDA PHARMACEUTICALS COM 921659108 447,798 43,874 10.86 6,412 52.92 0.0019
2014-11-13 2014-09-30 13F VANDA PHARMACEUTICALS COM 921659108 403,924 3,060 0.76 4,193 -35.35 0.0013
2014-08-14 2014-06-30 13F VANDA PHARMACEUTICALS COM 921659108 400,864 -47,223 -10.54 6,486 -10.92 0.0020
2014-05-14 2014-03-31 13F VANDA PHARMACEUTICALS COM 921659108 448,087 -44,319 -9.00 7,281 19.15 0.0023
2014-02-21 2013-12-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 492,406 45,012 10.06 6,111 24.74 0.0020
2014-02-12 2013-12-31 13F VANDA PHARMACEUTICALS COM 921659108 492,406 6,111
2013-11-13 2013-09-30 13F VANDA PHARMACEUTICALS COM 921659108 447,394 48,214 12.08 4,899 51.86 0.0017
2013-08-09 2013-06-30 13F VANDA PHARMACEUTICALS COM 921659108 399,180 399,180 3,226 0.0012
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.